Clinical Trial Update: Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating voriconazole plus micafungin versus voriconazole plus placebo for invasive aspergillosis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• Mycamine (Micafungin)
• VFEND (Voriconazole)

Snippet

Sponsor: University of Arkansas | Conditions: Aspergillosis | Phase 2 | Status: WITHDRAWN